Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urogenital Neoplasms × Biopsy × Clear all

Sponsor

Conditions

Breast Neoplasms 16 Lymphoma 12 Neoplasm Metastasis 9 Multiple Myeloma 9 Leukemia, Myeloid, Acute 8 Lung Neoplasms 7 Melanoma 6 Triple Negative Breast Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Lymphoma, Non-Hodgkin 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Carcinoma, Non-Small-Cell Lung 5 Neuroblastoma 4 Lymphoma, Follicular 4 Burkitt Lymphoma 4 Sarcoma, Kaposi 3 Prostatic Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Myeloproliferative Disorders 3 Myelodysplastic Syndromes 3 Malignant Solid Neoplasm 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Myelomonocytic, Acute 3 Leukemia 3 Hematologic Neoplasms 3 Head and Neck Neoplasms 3 HIV Infections 3 Fallopian Tube Neoplasms 3 Adenocarcinoma Of Esophagus 3 Wilms Tumor 2

Interventions

Sunitinib 2 Paclitaxel 2 valrubicin 1 temsirolimus 1 sipuleucel-T 1 luprolide acetate gel depot 1 ferumoxtran-10 1 abiraterone 1 abemaciclib 1 Suspensions 1 Surveys and Questionnaires 1 Standard of Care 1 Radiotherapy 1 Prednisone 1 Prednisolone 1 Powders 1 Pemetrexed 1 Neoadjuvant Therapy 1 Magnetic Resonance Spectroscopy 1 Leuprolide 1 Educational Status 1 Docetaxel 1 Bevacizumab 1 Administration, Intravesical 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡